D-2-Hydroxyglutaric aciduria: biochemical marker or clinical disease entity.

There is no fulltext present in this item.

Title:	D-2-Hydroxyglutaric aciduria: biochemical marker or clinical disease entity.
Author(s):	Knaap, M.S. van der; Jakobs, C.; Hoffmann, G.F.; Nyhan, W.L.; Renier, W.O. ; Smeitink, J.A.M. ; Catsman-Berrevoets, C.E.; Hjalmarson, O.; Vallance, H.; Sugita, K.; Bowe, C.M.; Herrin, J.T.; Craigen, W.J.; Buist, N.; Brookfield, D.S.; Chalmers, R.A.
Publication year:	1999
Source:	Annals of Neurology, vol. 45, iss. 1, (1999), pp. 111-119
ISSN:	0364-5134
DOI:	https://doi.org/10.1002/1531-8249(199901)45:1<111::AID-ART17>3.0.CO;2-N
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/184741
Display more details
Subject:	Epilepsy in mental retardation syndromes Inborn errors of metabolism Epilepsie bij mentale retardatie syndromen Erfelijke stofwisselingsziekten
Organization:	Neurology Paediatrics
Journal title:	Annals of Neurology
Volume:	vol. 45
Issue:	iss. 1
Page start:	p. 111
Page end:	p. 119